The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-5-(4-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-2-methylphenyl)-N-isopropyl-2-methylnicotinamide ID: ALA4849149
PubChem CID: 156646561
Max Phase: Preclinical
Molecular Formula: C25H25F2N3O3
Molecular Weight: 453.49
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(NC(=O)[C@H](O)c2cc(F)cc(F)c2)ccc1-c1cnc(C)c(C(=O)NC(C)C)c1
Standard InChI: InChI=1S/C25H25F2N3O3/c1-13(2)29-24(32)22-10-17(12-28-15(22)4)21-6-5-20(7-14(21)3)30-25(33)23(31)16-8-18(26)11-19(27)9-16/h5-13,23,31H,1-4H3,(H,29,32)(H,30,33)/t23-/m1/s1
Standard InChI Key: HZQGFXQCDQMBMH-HSZRJFAPSA-N
Molfile:
RDKit 2D
33 35 0 0 0 0 0 0 0 0999 V2000
5.8097 -3.4379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8086 -4.2575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5166 -4.6664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2263 -4.2570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2235 -3.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5148 -3.0291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1040 -3.0297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1051 -2.2114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3982 -1.8030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6896 -2.2119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6924 -3.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3999 -3.4379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9843 -3.4456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2751 -3.0397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9874 -4.2628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9346 -4.6645 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6417 -4.2548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3500 -4.6623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6404 -3.4376 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0571 -4.2526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7642 -4.6614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4707 -4.2524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4699 -3.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7566 -3.0270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0529 -3.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1789 -4.6602 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.7524 -2.2098 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.3513 -5.4795 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6966 -4.6687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6997 -5.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4028 -4.2574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1005 -4.6655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9812 -1.8044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
1 7 1 0
13 14 2 0
13 15 1 0
11 13 1 0
4 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
22 26 1 0
24 27 1 0
18 28 1 1
15 29 1 0
29 30 1 0
29 31 1 0
2 32 1 0
10 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 453.49Molecular Weight (Monoisotopic): 453.1864AlogP: 4.45#Rotatable Bonds: 6Polar Surface Area: 91.32Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.01CX Basic pKa: 4.14CX LogP: 3.54CX LogD: 3.54Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.51Np Likeness Score: -1.26
References 1. Calvo V, Surguladze D, Li AH, Surman MD, Malibhatla S, Bandaru M, Jonnalagadda SK, Adarasandi R, Velmala M, Singireddi DRP, Velpuri M, Nareddy BR, Sastry V, Mandati C, Guguloth R, Siddiqui S, Patil BS, Chad E, Wolfley J, Gasparek J, Feldman K, Betzenhauser M, Wiens B, Koszelak-Rosenblum M, Zhu G, Du H, Rigby AC, Mulvihill MJ.. (2021) Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious PERK kinase inhibitors., 43 [PMID:33895276 ] [10.1016/j.bmcl.2021.128058 ]